CWM
FOLD

CIBC World Markets’s Amicus Therapeutics FOLD Stock Holding History

CIBC World Markets’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$281K Buy
+19,710
New +$194K ﹤0.01% 982
2025
Q2 		$197K Sell
34,309
-30,799
-47% -$199K ﹤0.01% 1293
2025
Q1 		$531K Buy
65,108
+37,648
+137% +$348K ﹤0.01% 980
2024
Q4 		$259K Buy
+27,460
New +$285K ﹤0.01% 999

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIBC World Markets's FOLD Position: Q4 2025 in Review

CIBC World Markets opened a new position in Amicus Therapeutics (FOLD) in Q4 2025: 19,710 shares worth $281K. The stake represents ﹤0.01% of the portfolio and ranks #982 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in FOLD as recently as Q2 2025.

CIBC World Markets first reported a position in FOLD in Q4 2024 and has held it in 4 quarters since. The position peaked at $531K in Q1 2025. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • CIBC World Markets held 19,710 shares of Amicus Therapeutics worth $281K as of Q4 2025.
  • Amicus Therapeutics was a new CIBC World Markets position in Q4 2025.
  • Amicus Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #982 holding.
  • CIBC World Markets first reported a position in Amicus Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Amicus Therapeutics position peaked at $531K in Q1 2025.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.